Description
This product utilizes NK cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD138 (clone DOII6). We employs the HBV (EF1α-RFP-β-catenin-EcoRI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Adaptive feedback for a robust and sustained response against cancers.
Host
Human
Target
CD138
Clone
DOII6
Species Reactivity
Human
Cell Source
NK cells
Sensor Gene
RFP
Promoter
EF1α
Effector Gene
β-catenin
Insertion Sites
EcoRI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
HBV
Transformation Accuracy
0.95
Cell Culture
Aseptic Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.